Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
David Bouchey's Stock Ratings
Aegis Capital Analyst
David Bouchey is an analyst at Aegis Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/27/2025
Overall Average Return
-60.5%
Smart Score
Overall Average Return Percentile
2nd
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/05/2024 | SBFM | Buy Now | Sunshine Biopharma | $1.51 | 893.38% | David Bouchey13% | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
| 08/07/2023 | SBFM | Buy Now | Sunshine Biopharma | $1.51 | 72.19% | David Bouchey13% | → $2.6 | Initiates | → Buy | Get Alert |
| 05/09/2023 | STSS | Buy Now | Sharps Technology | $5.45 | 193.63% | David Bouchey13% | → $16 | Initiates | → Buy | Get Alert |
| 04/03/2023 | ATXI | Buy Now | Avenue Therapeutics | $0.24 | 13211.15% | David Bouchey13% | → $32 | Initiates | → Buy | Get Alert |
| 01/25/2023 | IINN | Buy Now | Inspira Technologies Oxy | $0.82 | 1483.05% | David Bouchey13% | $10 → $13 | Maintains | Buy | Get Alert |
| 10/19/2018 | RMTI | Buy Now | Rockwell Medical | $0.80 | 1278.45% | David Bouchey13% | → $11 | Downgrade | Strong Buy → Outperform | Get Alert |
| 08/14/2017 | RMTI | Buy Now | Rockwell Medical | $0.80 | 1278.45% | David Bouchey13% | → $11 | Initiates | → Strong Buy | Get Alert |
